• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconVaccines

Vaccines

Page 25 of 31
Joining WHO’s COVID vaccine program is a chance for China to exploit the U.S.’s absence
HealthJoining WHO’s COVID vaccine program is a chance for China to exploit the U.S.’s absence
By Eamon BarrettOctober 9, 2020
Photo of CEPI Deputy Director Frederik Kristensen
HealthWhich COVID-19 vaccine works best? A new lab network promises an answer
By Jeremy KahnOctober 6, 2020
Vials of AstraZeneca's Covid-19 vaccine.
HealthWith AstraZeneca’s COVID-19 vaccine trials on hold in the U.S., a gulf widens between America and other countries
By Jeremy KahnOctober 2, 2020
To ethically tackle COVID-19, Big Pharma needs an overhaul
CommentaryTo ethically tackle COVID-19, Big Pharma needs an overhaul
By Nicole HassounSeptember 25, 2020
Portrait of Pascal Soriot, AstraZeneca CEO
HealthUnder fire, AstraZeneca CEO defends transparency of COVID-19 vaccine trials
By Jeremy KahnSeptember 24, 2020
Where the 4 major coronavirus vaccine candidates currently stand
HealthWhere the 4 major coronavirus vaccine candidates currently stand
By Sy MukherjeeSeptember 23, 2020
CNV.10.20.Bill Gates Horizontal Featured
MagazineWhen Bill Gates thinks we’ll have a COVID-19 vaccine—and why that won’t be the end of the pandemic
By Clifton LeafSeptember 21, 2020
‘We’re racing against the clock’: The CEO of the Serum Institute of India on his company’s COVID-19 vaccine campaign
Health‘We’re racing against the clock’: The CEO of the Serum Institute of India on his company’s COVID-19 vaccine campaign
By Erika FrySeptember 21, 2020
‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
Magazine‘The whole world is coming together’: How the race for a COVID vaccine is revolutionizing Big Pharma
By Clifton LeafSeptember 21, 2020
Once a COVID-19 vaccine is discovered, the hard part begins
CommentaryOnce a COVID-19 vaccine is discovered, the hard part begins
By Ben HubbardSeptember 17, 2020
COVID-19 Vaccine Race Trials
Commentary6 questions that must be answered in the race for a vaccine
By Bill GeorgeSeptember 15, 2020
On COVID-19 vaccines, Big Pharma knows to just say ‘no’
CommentaryOn COVID-19 vaccines, Big Pharma knows to just say ‘no’
By Jeffrey Sonnenfeld and Albert KoSeptember 11, 2020
Close-up of someone receiving a vaccination.
HealthCOVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By Jeremy KahnSeptember 10, 2020
Gutting this federal program could undermine American confidence in a COVID vaccine
CommentaryGutting this federal program could undermine Americans’ confidence in a COVID vaccine
By Leah DurantSeptember 6, 2020
Preparation Of Independence Day In India
More than manufacturing: India’s homegrown COVID vaccines could transform its pharma industry
By Naomi Xu ElegantSeptember 5, 2020
1...
  • 23
  • 24
  • 25
  • 26
  • 27
...31
Most Popular
AI
Microsoft AI chief gives it 18 months—for all white-collar work to be automated by AIplaceholder alt text
By Jake AngeloMay 16, 2026
Success
Despite having a $165 million net worth, Scarlett Johansson says work-life balance doesn’t exist—and the first step to success is admitting thatplaceholder alt text
By Preston ForeMay 13, 2026
Politics
Former top Russian official admits the country is over Putin and can 'imagine a future without him' — even elites bail as Kremlin seizes their assets placeholder alt text
By Jason MaMay 16, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.